Despite its potential, miRNA therapy faces several challenges:
1. Stability: miRNAs are susceptible to degradation by nucleases in the bloodstream. 2. Delivery: Efficiently delivering miRNAs to target cells without off-target effects is difficult. 3. Immune Response: Nanocarriers can sometimes elicit an immune response, leading to inflammation and other side effects.
